These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8022396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug 10; 272(6):424-5. PubMed ID: 8040966
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.
    Williams IT, Bell BP, Kuhnert W, Alter MJ.
    Arch Intern Med; 2011 Feb 14; 171(3):242-8. PubMed ID: 21325115
    [Abstract] [Full Text] [Related]

  • 6. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1999 Jun 25; 48(24):518-21. PubMed ID: 10401909
    [Abstract] [Full Text] [Related]

  • 7. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP, Traineau R, Tuveri R, Ravera N, Bureau C, Gluckman E, Benbunan M, Loiseau P.
    Bone Marrow Transplant; 1996 Dec 25; 18(6):1131-3. PubMed ID: 8971383
    [Abstract] [Full Text] [Related]

  • 8. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RW, Simmonds P, Chapel H.
    Gastroenterology; 1996 Apr 25; 110(4):1120-6. PubMed ID: 8613001
    [Abstract] [Full Text] [Related]

  • 9. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A, Faulques B, Sevadjan B, Troalen D, Marais A, Barau G.
    Bull Soc Pathol Exot; 2000 Feb 25; 93(1):34-40. PubMed ID: 10774493
    [Abstract] [Full Text] [Related]

  • 10. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A, Doerr HW, Scharrer I, Weber B.
    J Med Virol; 1997 Sep 25; 53(1):25-30. PubMed ID: 9298728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatitis C following administration of intravenous immunoglobulins].
    Cabrera Chaves T, Simón Marco MA, Gomollón García F, Botella Esteban MT, Uribarrena Echebarría R.
    Gastroenterol Hepatol; 1996 Sep 25; 19(6):305-8. PubMed ID: 8754418
    [Abstract] [Full Text] [Related]

  • 13. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR.
    J Infect Dis; 2007 Nov 15; 196(10):1474-82. PubMed ID: 18008226
    [Abstract] [Full Text] [Related]

  • 14. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S, Fielding JF.
    Ital J Gastroenterol Hepatol; 1997 Feb 15; 29(1):47-50. PubMed ID: 9265578
    [Abstract] [Full Text] [Related]

  • 15. Outbreak of hepatitis C virus infection in an outpatient clinic.
    Ishikawa T, Fukushima Y, Shiobara Y, Kishimoto T, Tanno S, Shoji I, Suzuki T, Matsui T, Shimada Y, Ohyama T, Nagai R, Miyamura T.
    J Gastroenterol Hepatol; 2005 Jul 15; 20(7):1087-93. PubMed ID: 15955219
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
    Defossez G, Verneau A, Ingrand I, Silvain C, Ingrand P, Beauchant M, Poitou-Charentes Hepatitis C Network.
    Eur J Gastroenterol Hepatol; 2008 May 15; 20(5):367-72. PubMed ID: 18403936
    [Abstract] [Full Text] [Related]

  • 17. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C, Flynn MA, Promrat K.
    Am J Gastroenterol; 2008 Jan 15; 103(1):131-7. PubMed ID: 17894850
    [Abstract] [Full Text] [Related]

  • 18. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
    Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Abdel-Wahab A, Mikhail N, El-Kafrawy S, El-Daly M, Abdel-Aziz F, Sharaf S, Mohamed MK, Engle RE, Emerson SU, Purcell RH, Fix AD, Strickland GT.
    Clin Infect Dis; 2006 Mar 01; 42(5):628-33. PubMed ID: 16447107
    [Abstract] [Full Text] [Related]

  • 19. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L, Soumillion A, Peerlinck K, Verslype C, Schelstraete R, Gyselinck F, Emonds MP, Hess G, Vermylen J, Desmyter J, Yap SH.
    Thromb Haemost; 1998 Apr 01; 79(4):752-5. PubMed ID: 9569187
    [Abstract] [Full Text] [Related]

  • 20. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ, Maida I, Soriano V, Núnez M.
    J Hepatol; 2008 Sep 01; 49(3):323-8. PubMed ID: 18486266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.